Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) EPS (Weighted Average and Diluted): 2021-2024

Historic EPS (Weighted Average and Diluted) for Immunocore Holdings (IMCR) over the last 4 years, with Dec 2024 value amounting to -$1.02.

  • Immunocore Holdings' EPS (Weighted Average and Diluted) fell 102.29% to -$0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.57, marking a year-over-year increase of 39.59%. This contributed to the annual value of -$1.02 for FY2024, which is 9.73% up from last year.
  • According to the latest figures from FY2024, Immunocore Holdings' EPS (Weighted Average and Diluted) is -$1.02, which was up 9.73% from -$1.13 recorded in FY2023.
  • Immunocore Holdings' 5-year EPS (Weighted Average and Diluted) high stood at -$1.02 for FY2024, and its period low was -$4.24 during FY2021.
  • Over the past 3 years, Immunocore Holdings' median EPS (Weighted Average and Diluted) value was -$1.13 (recorded in 2023), while the average stood at -$1.10.
  • Data for Immunocore Holdings' EPS (Weighted Average and Diluted) shows a peak YoY surged of 72.88% (in 2022) over the last 5 years.
  • Immunocore Holdings' EPS (Weighted Average and Diluted) (Yearly) stood at -$4.24 in 2021, then surged by 72.88% to -$1.15 in 2022, then grew by 1.74% to -$1.13 in 2023, then grew by 9.73% to -$1.02 in 2024.